Paul A. Laviolette - Aug 9, 2024 Form 4 Insider Report for PULSE BIOSCIENCES, INC. (PLSE)

Role
Director
Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
Stock symbol
PLSE
Transactions as of
Aug 9, 2024
Transactions value $
$0
Form type
4
Date filed
8/13/2024, 07:37 PM
Previous filing
May 9, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLSE Stock Option (right to buy) Award $0 +50K $0.00 50K Aug 9, 2024 Common Stock 50K $15.65 Direct F1
transaction PLSE Stock Option (right to buy) Award $0 +200K $0.00 200K Aug 9, 2024 Common Stock 200K $15.65 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third of the shares subject to the option will vest on the one-year anniversary of the grant and the remaining shares will vest on a monthly basis over two years thereafter, subject to the Reporting Person's continued service through each vesting date.
F2 One-fourth of the shares subject to the option will vest on the date of the Issuer's next annual meeting of stockholders and the remaining shares will vest on a monthly basis over three years thereafter, subject to the Reporting Person's continued service through each vesting date.